XW0U0XB ICD-10-PCS Code: Introduction of Peptide Enhanced Bone Void Filler into Joints, Open Approach, New Technology Group 11

Related Codes

Same operation — other Approach

Same table and root operation, differing only in the approach character.

XW0U3XB — Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Approach, New Technology Group 11, XW0U4XB — Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Endoscopic Approach, New Technology Group 11

Same procedure category (CCSR), other tables

AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Administration of therapeutic substances, NEC (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.

3E0U3TZ — Introduction of Destructive Agent into Joints, Percutaneous Approach, 3E0U4GC — Introduction of Other Therapeutic Substance into Joints, Percutaneous Endoscopic Approach, 3E0V0GB — Introduction of Recombinant Bone Morphogenetic Protein into Bones, Open Approach, 3E0V0GC — Introduction of Other Therapeutic Substance into Bones, Open Approach, 3E0V3GB — Introduction of Recombinant Bone Morphogenetic Protein into Bones, Percutaneous Approach, 3E0V3GC — Introduction of Other Therapeutic Substance into Bones, Percutaneous Approach, 3E0V3TZ — Introduction of Destructive Agent into Bones, Percutaneous Approach, 3E0V4GC — Introduction of Other Therapeutic Substance into Bones, Percutaneous Endoscopic Approach, 3E0W3GC — Introduction of Other Therapeutic Substance into Lymphatics, Percutaneous Approach, 3E0W3TZ — Introduction of Destructive Agent into Lymphatics, Percutaneous Approach, 3E0X3GC — Introduction of Other Therapeutic Substance into Cranial Nerves, Percutaneous Approach, 3E0X3TZ — Introduction of Destructive Agent into Cranial Nerves, Percutaneous Approach, 3E0Y3GC — Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Approach, 3E0Y3SF — Introduction of Other Gas into Pericardial Cavity, Percutaneous Approach, 3E0Y3TZ — Introduction of Destructive Agent into Pericardial Cavity, Percutaneous Approach, 3E0Y4GC — Introduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Endoscopic Approach, 3E0Y7SF — Introduction of Other Gas into Pericardial Cavity, Via Natural or Artificial Opening, XY0VX83 — Extracorporeal Introduction of Endothelial Damage Inhibitor to Vein Graft, New Technology Group 3, XY0YX28 — Extracorporeal Introduction of Taurolidine Anti-infective and Heparin Anticoagulant, New Technology Group 8, XY0YX37 — Extracorporeal Introduction of Nafamostat Anticoagulant, New Technology Group 7, +213 more

Contextual Map

Every relationship of XW0U0XB in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

• XW0[PCS table]— CMS ICD-10-PCS tables
• New Technology — Section: New Technology[Section]: “New Technology”— CMS ICD-10-PCS tables
• Anatomical Regions — Body System: Anatomical Regions[Body System]: “Anatomical Regions”— CMS ICD-10-PCS tables
• Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables

Clinical classification (CCSR)

• ADM021 — Administration of therapeutic substances, NEC[CCSR category]: “Administration of therapeutic substances, NEC — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1

Nearest codes

• XW0U3XB — Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Approach, New Technology Group 11[One axis away]— CMS ICD-10-PCS tables
• XW0U4XB — Introduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Endoscopic Approach, New Technology Group 11[One axis away]— CMS ICD-10-PCS tables